Auteur N. KALK

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Naloxone dosing in the era of synthetic opioids: Applying the Goldilocks principle [Addiction opinion and debate]

M. GONZALEZ UTRILLA ; E. CHESNEY ; J. NEALE ; N. METREBIAN ; N. KALK ; A. K. SKULBERG ; P. DIETZE ; M. SMITH ; J. STRANG | 2025
Dans Addiction (Vol.120, n°11, November 2025) Article : Périodique

The opioid overdose epidemic remains a critical public health crisis. In recent years, synthetic opioids like fentanyl and nitazenes, have driven a sharp rise in deaths. Naloxone, an opioid receptor antagonist, has been established as a key inte[...]

Plus d'info

Ajouter à la sélection

Lien externe

Non-prescribed ketamine use is rising in the UK [Editorial]

I. GUERRINI ; N. KALK ; L. JELEN ; J. STRANG | 2025
Dans British Medical Journal (Vol.389, 2025) Article : Périodique

The rise in non-prescribed use of ketamine across the UK in recent years is concerning because of the potential effects on physical and mental wellbeing and overall quality of life. Despite its classification as a class B drug under the Misuse o[...]

Plus d'info

Ajouter à la sélection

Lien externe